Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China flag China · Delayed Price · Currency is CNY
33.83
+0.23 (0.68%)
At close: Apr 24, 2026

SHA:688139 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
2,3162,2742,2722,8552,119
Other Revenue
12.29.859.248.627.31
2,3292,2842,2812,8642,126
Revenue Growth (YoY)
1.96%0.13%-20.36%34.72%51.63%
Cost of Revenue
1,2471,1901,1741,4901,061
Gross Profit
1,0821,0941,1071,3741,065
Selling, General & Admin
552.22471.73476.68513.72388.03
Research & Development
323.25306.17320.64292.47236.31
Other Operating Expenses
-2.74-6.48-7.252.341.63
Operating Expenses
885.88787.08793.97809.08622.71
Operating Income
195.77306.58312.95564.67441.98
Interest Expense
-3.91-3.41-3.51-2.69-2.89
Interest & Investment Income
62.6871.46118.6495.02483.95
Currency Exchange Gain (Loss)
-2.384.46-7.723.584.14
Other Non Operating Income (Expenses)
-3.44-1.87-1.64-1.490.56
EBT Excluding Unusual Items
248.72377.21418.71659.1927.74
Gain (Loss) on Sale of Investments
-0.495.472.06-7.0110.21
Gain (Loss) on Sale of Assets
0.630.23-1.6-0.76-0.52
Asset Writedown
-1.23-1.86-2.36--
Other Unusual Items
17.1320.917.692423.44
Pretax Income
264.76401.96434.49675.34960.87
Income Tax Expense
9.6320.9522.4363.36111.7
Earnings From Continuing Operations
255.13381.01412.06611.97849.17
Minority Interest in Earnings
-4.4-14.38-5.99-11.18-4.14
Net Income
250.73366.63406.07600.79845.04
Net Income to Common
250.73366.63406.07600.79845.04
Net Income Growth
-31.61%-9.71%-32.41%-28.90%121.82%
Shares Outstanding (Basic)
313316317318316
Shares Outstanding (Diluted)
313316317318318
Shares Change (YoY)
-0.84%-0.37%-0.20%0.06%-2.43%
EPS (Basic)
0.801.161.281.892.67
EPS (Diluted)
0.801.161.281.892.66
EPS Growth
-31.03%-9.38%-32.27%-28.95%127.35%
Free Cash Flow
148.64164.9672.08338.18387.11
Free Cash Flow Per Share
0.470.520.231.061.22
Dividend Per Share
0.3300.4700.5150.4500.500
Dividend Growth
-29.79%-8.74%14.44%-10.02%31.61%
Gross Margin
46.45%47.89%48.53%47.97%50.08%
Operating Margin
8.41%13.42%13.72%19.72%20.79%
Profit Margin
10.77%16.05%17.80%20.98%39.75%
Free Cash Flow Margin
6.38%7.22%3.16%11.81%18.21%
EBITDA
303.74422.71410.67626.73491.15
EBITDA Margin
13.04%18.51%18.00%21.88%23.10%
D&A For EBITDA
107.97116.1397.7262.0649.17
EBIT
195.77306.58312.95564.67441.98
EBIT Margin
8.41%13.42%13.72%19.72%20.79%
Effective Tax Rate
3.64%5.21%5.16%9.38%11.63%
Revenue as Reported
2,3292,2842,2812,8642,126
Advertising Expenses
35.1624.8831.8225.4114.24
Source: S&P Global Market Intelligence. Standard template. Financial Sources.